RALLIDAE THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 06 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99070253
- Mark type
- Stylized text
- Filed
- 06 Mar 2025
- Published for opposition
- 09 Sept 2025
- Attorney of record
- John Lucas
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of metabolic diseases, cardiovascular diseases, respiratory diseases, autoimmune diseases and conditions, gastrointestinal diseases, liver diseases, renal diseases, urological diseases, neurological diseases, psychiatric disorders, dermatological diseases, ophthalmological diseases, and internal medical diseases and conditions.
Owner
- Rallidae Therapeutics, San Leandro, CA, US
- Rallidae Therapeutics, San Leandro, CA, US
Prosecution history
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 1 GRANTED
- 02 Apr 2026 — SOU EXTENSION 1 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2025 — ASSIGNED TO EXAMINER
- 06 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 06 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Mar 2025 — NEW APPLICATION ENTERED